← Markets

Universal Health Services, Inc.

UHS · NYSE

Market closed$151.16$-2.38 (-1.55%)After hours $151.30 · +0.09%

Key statistics

Previous close$153.54
Open$153.26
Day high$155.72
Day low$151.00
52-week high$246.33
52-week low$140.08
Market cap9.46B
Volume426.96K
Average volume1.05M
P/E ratio6.71
Forward P/E4.19
EPS22.54
Dividend yield+0.53%

Market context

Why it moved

UHS shares declined modestly amid broader sector pressure, as reports highlighting hidden hospital contracts keeping prices artificially high raised concerns about potential regulatory scrutiny and reimbursement headwinds for hospital operators, while the stock continues to trade well below its early-2026 highs despite steady underlying earnings momentum.

InquirerMarketbeatRedditNyuhsFacebook

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026Universal Health Services rallied alongside the broader healthcare sector after UnitedHealth Group reported a blowout Q2 2026 earnings beat — adjusted EPS of $6.38 vs. a $4.85 estimate — and raised its full-year guidance, easing industry-wide concerns about elevated medical costs and payer mix headwinds. The surge partially reverses UHS's sharp 5.6% drop on July 14, when HCA Healthcare's profit warning and rising nursing shortage data rattled hospital stocks; UHS reports its own Q2 results on July 27, with analysts watching volumes, Medicaid reimbursement trends, and the pending $835M Talkspace acquisition.

3.7292

July 16, 2026Universal Health Services shares recovered sharply, gaining over 2.6%, as investors appeared to buy the dip following the prior session's steep 5.6% selloff driven by sector-wide pressure. The rebound came even as hospital peer HCA Healthcare soared ~4% after its preliminary Q2 results, helping lift sentiment across the group. Key headwinds remain: a nursing shortage surge from 28% to 39% threatening labor costs, Medicaid reimbursement risk, and an upcoming July 27 earnings report that investors will scrutinize closely. UHS also declared its quarterly dividend of $0.20/share, payable September 15, while a median analyst price target of ~$195.50 suggests significant upside if sector pressures ease.

2.6277

July 15, 2026Universal Health Services tumbled nearly 5.6% to close at $144.23, approaching its 52-week low of $140.08, as peer HCA Healthcare's preliminary Q2 results sent shockwaves through the hospital sector. HCA disclosed that rising uninsured patient volumes drove an estimated $400 million pre-tax hit in Q2, with full-year ACA exchange impacts now expected to exceed $1 billion — amplifying fears that UHS faces similar headwinds from the expiration of enhanced ACA subsidies, which management had already flagged as a $75 million pretax drag. With UHS's own Q2 earnings due July 27, investors are bracing for potential guidance cuts, while analysts have been steadily trimming price targets — Mizuho cut its target to $200 from $230, Stephens to $170 from $205, and Barclays recently downgraded to Equal Weight with a $179 target — leaving the XLV healthcare sector ETF down on the day as well.

-5.5901

July 14, 2026Universal Health Services fell nearly 2% amid a broader market selloff driven by renewed U.S.-Iran hostilities and rising oil prices, compounding existing analyst pressure after Barclays downgraded the stock to Equal Weight on July 8 and both Wells Fargo and Mizuho trimmed their price targets on Monday. The wave of downgrades reflects sector-wide concerns about Medicaid reimbursement uncertainty, California staffing mandates, and the expiration of ACA subsidies — headwinds that have pushed the average analyst price target well above current trading levels, suggesting the market is pricing in meaningful execution risk around the pending Talkspace acquisition and the broader shift to value-based care.

-1.7998

July 11, 2026Universal Health Services closed little changed on the regular session, with shares edging up in after-hours trading, even as investor focus centers on two competing narratives: a Barclays downgrade to Equalweight (citing Medicaid cut uncertainty and payor mix concerns) versus bullish sentiment around the newly formed Capital Medical Group — a physician-led not-for-profit created through UHS's agreement with The George Washington University and Medical Faculty Associates. Some analysts peg fair value near $224, implying ~30% upside from current levels, with behavioral health positioned as a long-duration growth engine. Despite a 13% rebound from June lows, UHS remains down roughly 29% year-to-date, and investors are watching for reimbursement pressure and integration execution risks.

0.2384

July 10, 2026Universal Health Services edged modestly lower, pressured by a wave of analyst caution after Barclays downgraded UHS to Equalweight from Overweight and slashed its price target to $179 from $238, citing uncertainty around volumes, payor mix, and Medicaid cuts. Stephens also trimmed its price target to $170 from $205. The downgrades follow a 13% rebound in UHS shares since June lows, which Barclays flagged as having run ahead of fundamentals — even as the Capital Medical Group partnership with GW University draws strategic interest and Q2 earnings loom on July 27. Shares are rebounding +1.74% in after-hours trading.

-0.7863

July 8, 2026Universal Health Services declined sharply after Barclays downgraded the stock to Equal-Weight from Overweight and slashed its price target to $179 from $238, citing the need for greater clarity on volumes, payor mix, and Medicaid cuts. Analyst Andrew Mok noted that UHS has already rebounded 13% since June lows — outpacing the S&P 500's 1% gain — suggesting the recent rally has reduced the risk/reward. The stock is continuing to slide in after-hours trading, underperforming the broader healthcare sector (XLV essentially flat in extended hours) as investors also weigh the company's Q2 2026 earnings report scheduled for July 27.

-2.9952

July 8, 2026Universal Health Services gained over 2% as investors responded to a confluence of positive catalysts, including a proposed 2.4% CMS Medicare payment rate increase and analyst support — with TD Cowen maintaining a Buy rating despite trimming its price target to $197. The company also announced Q2 2026 earnings on July 27, drawing investor attention ahead of results, while its recently disclosed George Washington University hospital agreement to establish a physician-led Capital Medical Group highlights UHS's care delivery expansion. The stock, which remains down sharply year-to-date and trades at a steep P/E discount of ~6.3x versus the healthcare sector average of ~25.9x, attracted value-oriented investors as the broader XLV healthcare ETF closed near its 52-week high.

2.031

www.marketscreener.com · July 15, 2026UNIVERSAL HEALTH SERVICES : ANNOUNCES DIVIDEND »Quiver Quantitative · July 14, 2026Universal Health Services (UHS) Falls as Hospital-Sector Volume and Reimbursement Concerns Weigh on SharesTradingView · July 14, 2026Why Universal Health Services (UHS) Shares Are Trading Lower TodayTradingView · July 11, 2026UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALLTMX Newsfile · June 18, 2026UNIVERSAL HEALTH SERVICES, INC. INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services, Inc.'s Directors and Officers for Breach of Fiduciary Duties - UHSSimply Wall Street · May 26, 2026Universal Health Services Leadership Shift And Behavioral Health Valuation GapHealthcare Dive · March 9, 2026UHS to acquire Talkspace for $835M as hospital operator pursues behavioral health growthPR Newswire · March 9, 2026Universal Health Services, Inc. to Acquire Talkspace, Inc.
Mt Newswire · July 15, 2026Universal Health Services Keeps Quarterly Dividend at $0.20 a Share, Payable Sept. 15 to Holders of Record Sept. 1
Benzinga · July 13, 2026Wells Fargo Maintains Equal-Weight on Universal Health Services, Raises Price Target to $166
Mt Newswire · July 13, 2026Mizuho Adjusts Price Target on Universal Health Services to $200 From $230, Maintains Outperform Rating
Mt Newswire · July 13, 2026Wells Fargo Adjusts PT on Universal Health Services to $166 From $165, Maintains Equalweight Rating
Mt Newswire · July 9, 2026Stephens Adjusts Price Target on Universal Health Services to $170 From $205
Mt Newswire · July 8, 2026Universal Health Services Shares Fall After Downgrade From Barclays
Mt Newswire · July 8, 2026Barclays Downgrades Universal Health Services to Equal Weight From Overweight, Adjusts PT to $179 From $238
Benzinga · July 8, 2026Barclays Downgrades Universal Health Services to Equal-Weight, Announces $179 Price Target

Peers

S&P 500SPX · $7,457.78-1.01%HCA Healthcare, Inc.HCA · $371.18-3.77%Tenet Healthcare CorporationTHC · $194.91-2.15%Community Health Systems, Inc.CYH · $3.30-2.37%Acadia Healthcare Company, Inc.ACHC · $34.50+2.65%Encompass Health CorporationEHC · $112.21-0.25%DaVita Inc.DVA · $236.97+1.26%Fresenius Medical Care AG & Co. KGaAFMS · $24.11+0.08%The Ensign Group, Inc.ENSG · $171.28-0.93%BrightSpring Health Services, Inc. Common StockBTSG · $70.69+3.71%Surgery Partners, Inc.SGRY · $15.99-3.91%PACS Group, Inc.PACS · $46.13+1.10%